AstraZeneca moved the other way with a decline of 113p to 9865p, while housebuilders Persimmon and Taylor Wimpey lost about 0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback